Questa pagina è stata tradotta automaticamente e l'accuratezza della traduzione non è garantita. Si prega di fare riferimento al Versione inglese per un testo di partenza.

Thumb Muscle Activation During First Dorsal Interosseous Activities of Daily Living in Thumb Base Osteoarthritis

21 giugno 2026 aggiornato da: carmen menaya fernandez, University of Malaga

A Between-Group Comparison of First Dorsal Interosseous and Abductor Pollicis Longus Muscle Activation During First Dorsal Interosseous Activities of Daily Living in Individuals With and Without Thumb Base Osteoarthritis

The aim of this study is to investigate whether there are differences in muscle activation of the First Dorsal Interosseous (FDI) and the Abductor Pollicis Longus (APL) between individuals with and without trapeziometacarpal osteoarthritis (TMC OA) of the thumb during the performance of six activities of daily living (ADLs).

The FDI has been defined as a key stabilizer of the TMC joint of the thumb. However, the literature reports limited information on FDI and APL activation during ADLs. TMC OA of the thumb can cause pain, decreased thumb strength, impaired hand function, and difficulty performing ADLs. Understanding muscle activation patterns during these activities is essential to comprehend how this condition affects hand function and to guide more specific and effective rehabilitation strategies.

Participants will perform six ADLs: turning a key to open, turning a key to close, picking up a coin, writing, squeezing a tube of toothpaste, and holding a glass of water. Muscle activity will be recorded using surface electromyography (sEMG) during all tasks.

Adults aged 30 years and older, both men and women, with TMC osteoarthritis and healthy controls without osteoarthritis will be invited to participate.

Researchers will measure the activation patterns of the FDI and APL muscles during the ADLs, with the aim of identifying differences between both groups and providing evidence to guide the rehabilitation of patients with thumb base osteoarthritis.

Panoramica dello studio

Stato

Non ancora reclutamento

Descrizione dettagliata

Trapeziometacarpal osteoarthritis (OA TMC) of the thumb is a chronic and progressive degenerative disease characterized by loss of articular cartilage, subchondral sclerosis, capsuloligamentous laxity, and osteophyte formation in the first metacarpal. Patients typically present with pain and muscle weakness, which impair hand function and limit activities of daily living (ADLs), resulting in a considerable personal and social burden, including reduced quality of life and work disability. Previous studies have highlighted the clinical importance of thumb TMC joint stabilizers. Research has demonstrated that the first dorsal interosseous (FDI) functions as the main stabilizer of the TMC joint, whereas the abductor pollicis longus (APL) acts as a primary destabilizer. These findings suggest that rehabilitation programs should focus on strengthening the FDI to improve joint stability. However, despite the clinical importance of targeting these muscles, the literature reports limited information on how the FDI and APL behave during activities of daily living.

The aim of this study is to investigate whether there are differences in muscle activation of the FDI and APL between individuals with and without thumb OA TMC during the performance of six activities of daily living, in order to inform rehabilitation strategies. Adequate rehabilitation is essential for maintaining muscle function, slowing the progression of joint degeneration, and improving hand performance, yet it remains unclear how these muscles are engaged during functional daily tasks.

This is a cross-sectional observational comparative study with both within-subject and between-group analyses. The study includes two groups: adults aged 30 years and older, both men and women, with a clinical diagnosis of OA TMC and healthy controls without musculoskeletal or neurological disorders affecting the hand. Exclusion criteria include sensory disturbances such as numbness or tingling, cardiac pacemaker implantation, upper limb entrapment neuropathies or cervical radiculopathy, neuromuscular diseases, systemic conditions including diabetes or hypothyroidism, history of cancer, rheumatoid arthritis, anticoagulation therapy, chemotherapy, exposure to neurotoxins, or recent upper limb trauma or surgery.

Surface electromyography (sEMG) is used to record muscle activity of the FDI and APL. Skin is prepared by shaving if necessary and cleaning with alcohol to reduce impedance and ensure optimal adherence of surface electrodes. Bipolar surface electrodes with a diameter of 20 millimeters and an inter-electrode distance of 20 millimeters are placed according to SENIAM guidelines. For the FDI, electrodes are positioned over the dorsal belly of the muscle aligned with fiber direction, with one electrode in the distal ulnar region between the first and second metacarpals. For the APL, electrodes are placed approximately five centimeters distal to the wrist, medial to the radius, longitudinally aligned and transversely away from adjacent muscles. Electrode placement is verified by palpation and selective activation tasks.

Participants perform six standardized tasks simulating ADLs: turning a key toward the ulnar side, turning a key toward the radial side, picking up a coin, writing a word with a pen, squeezing a full tube of toothpaste, and holding a glass of water while performing a drinking gesture. Each task is performed in three consecutive three-second isometric repetitions with a thirty-second rest between repetitions to minimize fatigue.

It is hypothesized that individuals with thumb TMC osteoarthritis will demonstrate altered activation patterns of the FDI and APL compared with healthy controls, and that specific functional tasks will elicit greater FDI activation, supporting targeted interventions to enhance joint stability and hand function in patients with thumb base osteoarthritis.

Tipo di studio

Osservativo

Iscrizione (Stimato)

50

Contatti e Sedi

Questa sezione fornisce i recapiti di coloro che conducono lo studio e informazioni su dove viene condotto lo studio.

Contatto studio

  • Nome: CARMEN MENAYA FERNANDEZ, Doctoral Student
  • Numero di telefono: +34658424375
  • Email: cmenayaf@gmail.com

Luoghi di studio

    • Málaga
      • Málaga, Málaga, Spagna, 29071
        • Universidad de Málaga

Criteri di partecipazione

I ricercatori cercano persone che corrispondano a una certa descrizione, chiamata criteri di ammissibilità. Alcuni esempi di questi criteri sono le condizioni generali di salute di una persona o trattamenti precedenti.

Criteri di ammissibilità

Età idonea allo studio

  • Adulto
  • Adulto più anziano

Accetta volontari sani

Metodo di campionamento

Campione non probabilistico

Popolazione di studio

The study population will include adults aged 30 years and older, both men and women, divided into two groups. The first group will consist of individuals with a clinical diagnosis of thumb trapeziometacarpal osteoarthritis, and the second group will consist of healthy controls without musculoskeletal or neurological disorders affecting the hand.

Descrizione

Inclusion criteria for the TMC OA group:

- Clinical diagnosis of thumb TMC osteoarthritis.

Inclusion criteria for the healthy group:

- Participants with no history of musculoskeletal or neurological disorders affecting the dominant hand were included.

Exclusion Criteria :

  • Presence of numbness, tingling, or other sensory disturbances
  • Cardiac pacemaker implantation
  • Upper limb entrapment neuropathy or cervical radiculopathy
  • History of neuromuscular disease, polyneuropathy, or plexopathy
  • Systemic diseases such as diabetes, hypothyroidism, or chronic liver or kidney disease
  • History of cancer, rheumatoid arthritis, active anticoagulation therapy, chemotherapy, or exposure to neurotoxins
  • Recent upper limb soft tissue or bone injury (trauma, fracture, or surgery of the arm or neck).

Piano di studio

Questa sezione fornisce i dettagli del piano di studio, compreso il modo in cui lo studio è progettato e ciò che lo studio sta misurando.

Come è strutturato lo studio?

Dettagli di progettazione

Cosa sta misurando lo studio?

Misure di risultato primarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Surface electromyographic amplitude of the First Dorsal Interosseous muscle.
Lasso di tempo: Day 1
Mean surface electromyographic amplitude of the First Dorsal Interosseous muscle recorded during each of the 6 activities of daily living.
Day 1
Surface electromyographic amplitude of the Abductor Pollicis Longus muscle
Lasso di tempo: Day 1
Mean surface electromyographic amplitude of the Abductor Pollicis Longus muscle recorded during each of the 6 activities of daily living
Day 1

Collaboratori e investigatori

Qui è dove troverai le persone e le organizzazioni coinvolte in questo studio.

Pubblicazioni e link utili

La persona responsabile dell'inserimento delle informazioni sullo studio fornisce volontariamente queste pubblicazioni. Questi possono riguardare qualsiasi cosa relativa allo studio.

Pubblicazioni generali

Studiare le date dei record

Queste date tengono traccia dell'avanzamento della registrazione dello studio e dell'invio dei risultati di sintesi a ClinicalTrials.gov. I record degli studi e i risultati riportati vengono esaminati dalla National Library of Medicine (NLM) per assicurarsi che soddisfino specifici standard di controllo della qualità prima di essere pubblicati sul sito Web pubblico.

Studia le date principali

Inizio studio (Stimato)

5 giugno 2026

Completamento primario (Stimato)

30 agosto 2026

Completamento dello studio (Stimato)

30 agosto 2026

Date di iscrizione allo studio

Primo inviato

29 maggio 2026

Primo inviato che soddisfa i criteri di controllo qualità

21 giugno 2026

Primo Inserito (Effettivo)

25 giugno 2026

Aggiornamenti dei record di studio

Ultimo aggiornamento pubblicato (Effettivo)

25 giugno 2026

Ultimo aggiornamento inviato che soddisfa i criteri QC

21 giugno 2026

Ultimo verificato

1 giugno 2026

Maggiori informazioni

Termini relativi a questo studio

Piano per i dati dei singoli partecipanti (IPD)

Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?

NO

Informazioni su farmaci e dispositivi, documenti di studio

Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti

No

Studia un dispositivo regolamentato dalla FDA degli Stati Uniti

No

Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .

Sottoscrivi